Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tümmler, B.
180  Ergebnisse:
Personensuche X
?
1

WS16.01 Highly-effective CFTR modulator therapy with elexac..:

Dittrich, A. ; Sieber, S. ; Naehrlich, L....
Journal of Cystic Fibrosis.  22 (2023)  - p. S29-S30 , 2023
Link: https://doi.org/10.1016/..
 
?
2

P053 Spirometric and anthropometric improvements in respons..:

Schütz, K. ; Pallenberg, S. ; Sukdolak, C....
Journal of Cystic Fibrosis.  22 (2023)  - p. S79 , 2023
Link: https://doi.org/10.1016/..
 
?
3

599 Highly-effective CFTR modulator therapy with elexacafto..:

Dittrich, A. ; Sieber, S. ; Naehrlich, L....
Journal of Cystic Fibrosis.  22 (2023)  - p. S318 , 2023
Link: https://doi.org/10.1016/..
 
?
4

WS21.06 The β-adrenergic sweat secretion test using the Aut..:

Pallenberg, S.T. ; Dopfer, C. ; Minso, R....
Journal of Cystic Fibrosis.  21 (2022)  - p. S41 , 2022
Link: https://doi.org/10.1016/..
 
?
5

ECFS standards of care on CFTR-related disorders: Diagnosti..:

Sermet-Gaudelus, I. ; Girodon, E. ; Vermeulen, F....
Journal of Cystic Fibrosis.  21 (2022)  6 - p. 922-936 , 2022
Link: https://doi.org/10.1016/..
 
?
6

184 Effects of elexacaftor/tezacaftor/ivacaftor therapy on ..:

Graeber, S. ; Renz, D. ; Stahl, M....
Journal of Cystic Fibrosis.  21 (2022)  - p. S108 , 2022
Link: https://doi.org/10.1016/..
 
?
7

WS06.04 Effects of elexacaftor/tezacaftor/ivacaftor therapy..:

Graeber, S.Y. ; Vitzthum, C. ; Pallenberg, S.T....
Journal of Cystic Fibrosis.  21 (2022)  - p. S12 , 2022
Link: https://doi.org/10.1016/..
 
?
8

WS06.3 High-efficient CFTR modulation does not normalise ß-..:

Pallenberg, S. ; Nietert, M. ; Minso, R...
Journal of Cystic Fibrosis.  20 (2021)  - p. S11-S12 , 2021
Link: https://doi.org/10.1016/..
 
?
9

P001 TCRß repertoire in monozygotic cystic fibrosis twins:

Tümmler, B. ; Fischer, S. ; Stanke, F.
Journal of Cystic Fibrosis.  20 (2021)  - p. S39 , 2021
Link: https://doi.org/10.1016/..
 
?
10

P150 Competitive fitness experiments of cystic fibrosis iso..:

Cramer, N. ; Nawrot, M.-L. ; Wege, L....
Journal of Cystic Fibrosis.  20 (2021)  - p. S85 , 2021
Link: https://doi.org/10.1016/..
 
?
11

WS13.1 Rare species may act as problem-solvers in critical ..:

Pust, M.-M. ; Tümmler, B.
Journal of Cystic Fibrosis.  20 (2021)  - p. S25 , 2021
Link: https://doi.org/10.1016/..
 
?
12

P036 Analysis of the dysfunction of cystic fibrosis macroph..:

Rodriguez Gonzalez, C. ; Tschritter, D. ; Brinkert, K....
Journal of Cystic Fibrosis.  20 (2021)  - p. S49 , 2021
Link: https://doi.org/10.1016/..
 
?
13

WS08.2 The first time point of Pseudomonas aeruginosa ident..:

Pust, M.-M. ; Rudolf, I. ; Dittrich, A.-M...
Journal of Cystic Fibrosis.  19 (2020)  - p. S13 , 2020
Link: https://doi.org/10.1016/..
 
?
14

WS09.1 ICM and NPD diagnostics of cases with inconclusive C..:

Minso, R. ; Schulz, A. ; Dopfer, C....
Journal of Cystic Fibrosis.  19 (2020)  - p. S15 , 2020
Link: https://doi.org/10.1016/..
 
?
15

ePS3.01 Immunotyping of clinically divergent F508del homozy..:

Tümmler, B. ; Hedtfeld, S. ; Wiehlmann, L..
Journal of Cystic Fibrosis.  19 (2020)  - p. S43 , 2020
Link: https://doi.org/10.1016/..
 
1-15